Phospholipase PLA2G16 Accelerates the Host Interferon Signaling Pathway Response to FMDV

Bingjie Sun1, Xiaodong Qin1, Taoqing Zhang1

  • 1State Key Laboratory for Animal Disease Control and Prevention, National Foot and Mouth Disease Reference Laboratory, Lanzhou Veterinary Research Institute, Chinese Academy of Agricultural Sciences, Lanzhou 730046, China.

Viruses
|July 30, 2025
PubMed

Insights

Phospholipase A2 Group 16 (PLA2G16) enhances the innate immune response against Foot-and-Mouth Disease Virus (FMDV). Overexpression of PLA2G16 boosts antiviral defenses by activating interferon signaling pathways.

Area of Science:

  • Virology
  • Immunology
  • Molecular Biology

Background:

  • Phospholipase A2 Group 16 (PLA2G16) is known to be a host factor for picornaviruses.
  • PLA2G16 hydrolyzes phosphatidic acid into lysophosphatidic acids and free fatty acids.

Purpose of the Study:

  • To investigate the role of PLA2G16 in the host's response to Foot-and-Mouth Disease Virus (FMDV) infection.
  • To elucidate the mechanism by which PLA2G16 influences antiviral immunity against FMDV.

Main Methods:

  • Established PLA2G16 overexpression and knockdown cell lines in PK-15 cells.
  • Analyzed the expression of interferon-stimulating genes (ISG15, ISG56) and phosphorylated STAT1 (p-STAT1) during FMDV infection.
  • Assessed the impact of PLA2G16 on the interferon signaling pathway activation.

Main Results:

  • FMDV infection elevated PLA2G16 transcription.
  • PLA2G16 overexpression enhanced antiviral innate immunity against FMDV.
  • PLA2G16-overexpressing cells showed increased p-STAT1, ISG15, and ISG56 levels, indicating triggered interferon signaling.
  • Supernatants from PLA2G16-overexpressing cells activated innate immunity in uninfected cells.

Conclusions:

  • PLA2G16 plays a crucial role in promoting an antiviral innate immune response against FMDV.
  • PLA2G16 facilitates the early detection of viral nucleic acid and subsequent interferon pathway activation.
  • PLA2G16-expressing cells can prime uninfected cells to mount a stronger antiviral defense.